Peptris Technologies Secures ₹86 Crore for AI-Discovered Drug Candidates
The Story:
Peptris Technologies has secured ₹86 crore under India’s RDI Fund to advance four AI-discovered drug candidates through preclinical development and IND-enabling studies.
The Take:
The funding supports Peptris’ efforts to translate AI-driven drug discovery into development-ready therapies, with progress dependent on successful preclinical validation and regulatory requirements.
NuSynth Technologies Raises ₹36.5 Crore for AI-Driven Chemical Synthesis
The Story:
NuSynth Technologies has raised ₹36.5 crore in seed funding co-led by Avaana Capital and Shastra VC to develop its AI-driven chemical synthesis platform and scale its initial portfolio.
The Take:
The funding supports AI-enabled chemical process innovation, with potential to improve manufacturing efficiency, scalability and sustainability.
